BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 3096342)

  • 21. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
    Saniabadi AR; Belch JJ; Lowe GD; Barbenel JC; Forbes CD
    Haemostasis; 1987; 17(3):147-53. PubMed ID: 2440771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential inhibition of the platelet activation sequence: shape change, micro- and macro-aggregation, by a stable prostacyclin analogue (Iloprost).
    Pedvis LG; Wong T; Frojmovic MM
    Thromb Haemost; 1988 Apr; 59(2):323-8. PubMed ID: 2455359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of PGI2 on platelet aggregation induced by various stimulants.
    Ohtsu A; Hoshina K; Kurozumi S; Hashimoto Y; Noguchi T; Nicolaou KC
    Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):659-66. PubMed ID: 388963
    [No Abstract]   [Full Text] [Related]  

  • 24. The release of prostacyclin (PGI2) by pentoxifylline from human vascular tissue.
    Matzky R; Darius H; Schrör K
    Arzneimittelforschung; 1982; 32(10):1315-8. PubMed ID: 6817760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The in vitro effect of amrinone on platelet aggregation in human whole blood.
    Pattison A; Eason CT; Bonner FW
    Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):261-4. PubMed ID: 3083485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations].
    Nubile G; Di Gregorio M; Ridolfi D; D'Alonzo L; Izzi L
    Quad Sclavo Diagn; 1987 Sep; 23(3):331-40. PubMed ID: 3140287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of equine platelet function by diethylcarbamazine (DEC).
    Kowalski KA; McConnell LA; Sadoff DA; Leid RW
    Am J Pathol; 1983 Oct; 113(1):1-7. PubMed ID: 6414306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquisition and aggregation of canine blood platelets: basic mechanisms of function and differences because of breed origin.
    Clemmons RM; Meyers KM
    Am J Vet Res; 1984 Jan; 45(1):137-44. PubMed ID: 6422804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet sensitivity to prostacyclin in pregnancy and uterine cancer.
    Briel RC; Lippert TH
    Eur J Obstet Gynecol Reprod Biol; 1981 Jun; 12(1):19-23. PubMed ID: 7018952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human rhabdosarcoma cell-induced aggregation of blood platelets.
    Longenecker GL; Beyers BJ; Bowen RJ; King T
    Cancer Res; 1989 Jan; 49(1):16-9. PubMed ID: 2491750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ethanol on pathways of platelet aggregation in vitro.
    Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
    Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of VIP and epoprostenol on platelet CD62P expression and primary haemostasis in vitro.
    Zwerina J; Landsteiner H; Leitgeb U; Volf I; Petkov V; Zimpfer M; Blaicher A
    Platelets; 2004 Feb; 15(1):55-60. PubMed ID: 14985177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of whole blood platelet aggregation by nicardipine, and synergism with prostacyclin in-vitro.
    Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
    Thromb Res; 1986 Feb; 41(4):509-18. PubMed ID: 3083526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostacyclin (PGI2) inhibits the development in human platelets of ADP and arachidonic acid-induced shape change and procoagulant activity.
    Ehrman ML; Jaffe EA
    Prostaglandins; 1980 Dec; 20(6):1103-16. PubMed ID: 7010448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coffee extracts inhibit platelet aggregation in vivo and in vitro.
    Bydlowski SP; Yunker RL; Rymaszewski Z; Subbiah MT
    Int J Vitam Nutr Res; 1987; 57(2):217-23. PubMed ID: 3115908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased platelet activity after termination of prostacyclin infusion into man.
    Dembinska-Kiec A; Zmuda A; Grodzinska L; Bieron K; Basista M; Kedzior A; Kostka-Trabka E; Telesz E; Zelazny T
    Prostaglandins; 1981 May; 21(5):827-32. PubMed ID: 6803307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The novel effect of a new prostacyclin analogue ZK36374 on the aggregation of human platelets in whole blood.
    Saniabadi AR; Lowe GD; Belch JJ; Forbes CD; Prentice CR; Barbenel JC
    Thromb Haemost; 1983 Oct; 50(3):718-21. PubMed ID: 6196854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemin affects platelet aggregation and lymphocyte mitogenicity in whole blood incubations.
    Malik Z; Creter D; Cohen A; Djaldetti M
    Cytobios; 1983; 38(149):33-8. PubMed ID: 6313299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aqueous extracts of onion, garlic and ginger inhibit platelet aggregation and alter arachidonic acid metabolism.
    Srivastava KC
    Biomed Biochim Acta; 1984; 43(8-9):S335-46. PubMed ID: 6440548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.